IL-25 (also known as IL-17E) is elevated in patients with active SLE and exhibits immunoregulatory functions by suppressing proinflammatory cytokines such as IL-1β, IL-6, and IL-17A. Here, IL17A is linked to systemic lupus erythematosus.